Nephros (NEPH) EPS (Basic) Growth (5y) (2015 - 2026)
Nephros (NEPH) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Nephros | 48.26 Mn | 43.56 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.94% |
| Mar 31, 2026 | 15.38% |
| Dec 31, 2025 | 15.60% |
| Sep 30, 2025 | 17.79% |
| Jun 30, 2025 | 16.18% |
| Mar 31, 2025 | 8.84% |
| Dec 31, 2024 | 26.76% |
| Sep 30, 2024 | 16.72% |
| Jun 30, 2024 | 27.34% |
| Mar 31, 2024 | 36.87% |
| Dec 31, 2023 | 8.05% |
| Sep 30, 2023 | 25.54% |
| Jun 30, 2023 | 18.02% |
| Mar 31, 2023 | 31.40% |
| Dec 31, 2022 | -21.63% |
| Sep 30, 2022 | -25.54% |
| Jun 30, 2022 | 1.82% |
| Mar 31, 2022 | -10.33% |
| Dec 31, 2021 | -1.82% |
| Sep 30, 2021 | 1.22% |